العلوم والأبحاث

الدراسات المرجعية

• Diabetes Australia (2015) Type 1 Diabetes. https://www.diabetesaustralia.com.au/type-1-diabetes Accessed 23rd October 2018
• Bristol-Myers Squibb Company. (2017) GGLUCOSPHAGE® (metformin hydrochloride) Tablets & GLUCOPHAGE® XR (metformin hydrochloride) Extended-Release Tablets - Product Information. https://packageinserts.bms.com/pi/pi_glucophage_xr.pdf
• Aroda, V. R., et al. (2016) Long-term Metformin Use and Vitamin B12 Deficiency in the Diabetes Prevention Program Outcomes Study. J Clin Endocrinol Metab., 101:4, 1754–1761. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4880159/
• Sanchez-Rangel, E. & Izucchi, S. E. (2017) Metformin: clinical use in type 2 diabetes. Diabetologia, 60:9, 1586 - 1593. https://link.springer.com/article/10.1007%2Fs00125-017-4336-x
• Pitocco, D., et al. (2008) Unmet needs among patients with type 2 diabetes and secondary failure to oral anti-diabetic agents. J Endocrinol Invest., 31:4, 371 - 379. https://www.ncbi.nlm.nih.gov/pubmed/18475058
• Brown, J. B., et al. (2010) Secondary Failure of Metformin Monotherapy in Clinical Practice. Diabetes Care., 33:3, 501 - 506. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2827496/
• Pandey, A., et al. (2011) J Pharm Bioallied Sci., 3:4, 504 - 512. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3249697/
• Opinion Matters (2018) CCD PR Diabetes. https://curalife.com/wp-content/uploads/2018/10/Survey-results.pptx Accessed 23 October 2018.
• sanofi-aventis U.S. LLC. (2015) APIDXRA Prescribing Information. http://products.sanofi.us/apidra/apidra.html Accessed 23 October 2018
• World Health Organization (2017) Diabetes. http://www.who.int/news-room/fact-sheets/detail/diabetes Accessed 25 October 2018
• Momordica charantia and type 2 diabetes: from in vitro to human studies Curr Diabetes Rev. 2014 Jan;10(1):48-60..Habicht SD, Ludwig C, Yang RY, Krawinkel MB.
• Traditional Indian medicines used for the management of diabetes mellitus. J Diabetes Res. 2013. Syed Ibrahim Rizvi et al.
• Beneficial effect and mechanism of action of Momordica Charantia in the treatment of diabetes mellitus: a mini review. Int J Diabetes & Metabolism (2003) 11: 46-55. Celia Garau et al.
• Wild bitter gourd improves metabolic syndrome: a preliminary dietary supplementation trial. Nutrition Journal, vol. 11, no. 1, article 4, 2012.C. Tsai, E. C. Chen et al.
• Hypoglycemic effect of bitter melon compared with metformin in newly diagnosed type 2 diabetes patients. J Ethnopharmacol. 2011 Mar 24;134(2):422-8. Fuangchan A et al.
• www.thorne.com/altmedrev/.fulltext/4/1/46.pdf.
• An overview on the advances of Gymnema Sylvestre: chemistry, pharmacology and patents. Pharmazie. 2003 Jan;58(1):5-12.Porchezhian E et al.
• A systematic review of Gymnema Sylvestre in obesity and diabetes management. J Sci Food Agric. 2014 Mar 30;94(5):834-40.Pothuraju R et al.al.
• An overview on antidiabetic medicinal plants having insulin mimetic property. Asian Pac J Trop Biomed. 2012 Apr;2(4):320-30.Patel DK et al.
• www.diabetesincontrol.com/articles/uncategorized/10355-effect-of-extended-release- gymnema-sylvestre-leaf- extract-beta-fast-gxr.
• www.diabeteslibrary.org/View.aspx?url=Gymnema_sylvestre. et al.
• Effect of Trigonella Foenum-Graecum (fenugreek) seeds on glycaemic control and insulin resistance in type 2 diabetes mellitus: a double blind placebo controlled study. J Assoc Physicians India. 2001 Nov;49:1057-61.Gupta A
• Curcumin and diabetes: a systematic review. Evid Based Complement Alternat Med. 2013 Nov 24.Zhang DW et al.
• Curcumin extract for prevention of type 2 diabetes: Diabetes Care. 2012 Nov;35(11):2121-7. Chuengsamarn S et al.
• Antidiabetic Activity of Emblica Officinalis Seed Extract in Streptozotocin induced Type 2 Diabetes mellitus in Rat. Parminder N. et al. International Journal of Natural Product Science 2012: Spl Issue 1:135.
• Anti-diabetic activity of Emblica Officinalis in animal models: http://informahealthcare.com/doi/abs/10.3109 /13880200902991532
• Swertia Chirayita- an overview P. Joshi1,* and V. Dhawan, CURRENT SCIENCE, VOL. 89, NO. 4, 25 AUG 2005
• BLOOD SUGAR LOWERING ACTIVITY OF SWERTIA CHIRAYITA ROXB. EX. FLEM KARST IN DIFFERENT EXPERIMENTAL RAT MODELS: www.academia.edu/465211
• Experimental Evaluation of antidiabetic activity of Swertia Chirata – Aqueous Extract. J Pub Health Med Res 2013;1(2):71-75.2 Kavitha K.N. et al.
• Antidiabetic activity of standardized extract of Picrorhiza kurroa in rat model of NIDDM. Drug Discov Ther. 2009; 3(3):88-92.Gulam M.H. et al.
• Hypoglycemic and hypolipidemic effect of ethanolic extract of seeds of Eugenia jambolana in alloxan-induced diabetic rabbits. Journal of Ethnopharmacology. Volume 85, Issues 2–3, April 2003, Pages 201–206. Sharma S.B. et al.
• Preclinical evaluation of the antidiabetic effect of Eugenia jambolana seed powder in streptozotocin-diabetic rats. Braz J Med Biol Res, March 2005, Volume 38(3) 463-468. Sridhar S.B. et al.
• Anti-diabetic properties of Tinospora cordifolia stem extracts on streptozotocin-induced diabetic rats. African Journal of Pharmacy and Pharmacology 2009 Vol. 3 No. 5 pp. 171-180. Rajalakshmi. My. et al.
• Tinospora cordifolia attenuates oxidative stress and distorted carbohydrate metabolism in experimentally induced type 2 diabetes in rats. J Nat Med. 2011 Jul;65(3-4):544-50. Sangeetha MK/ et al.
• Clinical investigation of hypoglycemic effect of seeds of Azadirachta-indica in type-2 (NIDDM) diabetes mellitus. Pak J Pharm Sci. 2006 Oct;19(4):322-5. Waheed A. et al.
• Antidiabetic and hypolipidemic effects of few common plants extract in Type 2 Diabetic patients at Bengal. Int J Diabetes & Metab (2010) 18:59-65. Balasubramaniam D. et